<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Urinary NGAL-Positive Acute Kidney Injury and Poor Long-term Outcomes in Hospitalized Patients</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-07-24">24 July 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Eugenia</forename><surname>Singer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Nephrology</orgName>
								<address>
									<settlement>CharitéeUniversitätsmedizin Berlin, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Max Delbrück Center for Molecular Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eva</forename><forename type="middle">V</forename><surname>Schrezenmeier</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Nephrology</orgName>
								<address>
									<settlement>CharitéeUniversitätsmedizin Berlin, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Max Delbrück Center for Molecular Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Antje</forename><surname>Elger</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Max Delbrück Center for Molecular Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Evelyn</forename><forename type="middle">R</forename><surname>Seelow</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Nephrology</orgName>
								<address>
									<settlement>CharitéeUniversitätsmedizin Berlin, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alexander</forename><surname>Krannich</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Biostatistics</orgName>
								<orgName type="laboratory">Clinical Research Unit</orgName>
								<orgName type="institution" key="instit1">Berlin Institute of Health</orgName>
								<orgName type="institution" key="instit2">CharitéeUniversity Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Friedrich</forename><forename type="middle">C</forename><surname>Luft</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">Kai</forename><forename type="middle">M</forename><surname>Schmidt-Ott</surname></persName>
							<email>kai.schmidt-ott@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Nephrology</orgName>
								<address>
									<settlement>CharitéeUniversitätsmedizin Berlin, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Max Delbrück Center for Molecular Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Max-Delbrück Center</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Nephrology</orgName>
								<orgName type="department" key="dep2">Max Delbrueck Center for Molecular Medicine</orgName>
								<address>
									<addrLine>Robert-Rössle-Str 10</addrLine>
									<postCode>13125</postCode>
									<settlement>Charité Berlin, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Urinary NGAL-Positive Acute Kidney Injury and Poor Long-term Outcomes in Hospitalized Patients</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-07-24">24 July 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">F79526BA8A55B94E28D29B2DBDE41E2E</idno>
					<idno type="DOI">10.1016/j.ekir.2016.07.003</idno>
					<note type="submission">Received 11 April 2016; revised 13 July 2016; accepted 14 July 2016;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:20+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>acute kidney injury</term>
					<term>long-term outcomes</term>
					<term>neutrophil gelatinase-associated lipocalin (NGAL)</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Introduction: Neutrophil gelatinaseÀassociated lipocalin (NGAL) is a widely studied biomarker of renal tubular injury.</s><s>Urinary NGAL (uNGAL) during acute kidney injury (AKI) predicts short-term adverse outcomes.</s><s>However, the long-term predictive value is unknown.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods:</head><p><s>We performed a prospective observational study of 145 patients with hospital-acquired AKI according to Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease (RIFLE) criteria and analyzed the long-term predictive value of uNGAL at the time of AKI.</s><s>We defined a composite outcome of all-cause mortality and the development of end-stage renal disease (ESRD).</s></p><p><s>Results: In all, 61 AKI patients died and 22 developed ESRD within 6 months.</s><s>The uNGAL levels were significantly higher in patients with poor long-term outcomes.</s><s>uNGAL levels $362 mg/l (highest quartile) and uNGAL levels between 95 and 362 mg/l (third quartile) were associated with hazard ratios of 3.7 (95% confidence interval, 2.1-6.5) and 1.9 (1.1-3.5),</s><s>respectively, compared with uNGAL levels &lt;95 mg/l (lower quartiles).</s><s>After 6 months, 67% and 43% of patients within the highest and third uNGAL quartile, respectively, had either progressed to ESRD or died, compared to only 21% of patients with uNGAL in the lower 2 quartiles (P &lt; 0.001).</s><s>In multivariable Cox regression analyses accounting for conventional predictors, uNGAL was the strongest independent predictor of adverse long-term outcomes.</s><s>The association of uNGAL levels and poor long-term outcomes remained significant in the subgroup of 107 AKI survivors discharged without requiring dialysis (P ¼ 0.002).</s></p><p><s>Discussion: These data indicate that elevated uNGAL levels at AKI diagnosis predict poor long-term outcomes.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>a growing body of data to support the use of AKI biomarkers, the 10th Acute Dialysis Quality Initiative (ADQI) conference recommended that new biomarkers such as NGAL be included when diagnosing and staging AKI because of their sensitivity and prognostic importance. <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25</ref></s><s>NGAL is a 25-kDa protein belonging to the lipocalin family.</s><s>NGAL is produced in renal epithelia in response to nephron injury.</s><s>6]<ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref> NGAL effectively discriminates patients in the emergency room with intrinsic AKI from patients with prerenal azotemia, those with chronic kidney disease (CKD), and those with normal renal function. <ref type="bibr" target="#b20">21</ref></s><s>High NGAL levels are associated with adverse outcomes, including in-hospital mortality and death. <ref type="bibr" target="#b20">21</ref></s><s>Although most studies have addressed the utility of NGAL in predicting short-term poor clinical outcomes in AKI, <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref> the role of NGAL in predicting long-term outcomes is unclear.</s><s>Here, we provide evidence that high urinary NGAL (uNGAL) levels at the time of AKI diagnosis predict long-term adverse outcomes, including mortality and the development of ESRD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Design and Patient Cohort</head><p><s>During 2008 to 2009, a total of 145 patients with hospital-acquired AKI were enrolled in a prospective observational study to assess the utility of uNGAL, measured at the time of AKI, to predict inhospital outcome and diagnosis, as previously reported. <ref type="bibr" target="#b45">46</ref></s><s>Briefly, all hospitalized patients meeting the RIFLE criteria were eligible and were generally enrolled at the time of nephrology consultation.</s><s>Based on diagnostic adjudications, 32 patients had prerenal AKI and 75 patients had intrinsic AKI (the remaining 38 patients could not be classified based on the available clinical data). <ref type="bibr" target="#b45">46</ref></s><s>We assessed longterm outcomes of death or development of ESRD in this cohort.</s></p><p><s>Definitions AKI was defined according to creatinine-based RIFLE criteria (either a &gt;50% increase in serum creatinine concentration or a &gt;25% decrease in glomerular filtration rate compared with baseline).</s><s>ESRD was defined as a sustained (&gt;3 months) requirement of renal replacement therapy.</s><s>Follow-up of patients was achieved using the hospital electronic database; if information was insufficient, we contacted the general practitioner or nephrologist of the patient.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Duration</head><p><s>We performed the observation from November 2008 until August 2012.</s><s>The median follow-up period was 6 months.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outcome</head><p><s>The composite outcome included new-onset ESRD and all-cause mortality.</s><s>Time to event was calculated between the date of study inclusion (day of urinary sampling) and the first occurrence of an aspect of the composite outcome (ESRD or death).</s><s>We compared the predictive value of uNGAL levels to conventional predictors of adverse AKI outcomes (serum creatinine, RIFLE, and AKIN stages) as well as demographic factors and comorbidities.</s></p><p><s>uNGAL Measurements Urinary samples were obtained, and uNGAL was determined on stored samples (À80 C) using a standardized clinical platform (Abbott Architect), as reported in our previous publication. <ref type="bibr" target="#b45">46</ref></s><s>Briefly, the assay used a chemiluminescent microparticle immunoassay using a noncompetitive, 2-antianalyte antibody sandwich, which included a microparticle reagent prepared by covalently attaching an antianalyte antibody to paramagnetic particles and a conjugate reagent prepared by labeling a second antianalyte antibody with acridinium.</s><s>The chemiluminescent signal was calibrated using known quantities of recombinant NGAL.</s><s>As reported earlier, coefficients of variation were 3.0% for uNGAL at a concentration of 385 ng/ml. <ref type="bibr" target="#b46">47</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Informed Consent and Ethics</head><p><s>The Charité University Ethics Committee approved the study (EA3/011/08), and written informed consent was obtained from patients at the time point of enrollment. <ref type="bibr" target="#b45">46</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>We performed Kaplan-Meier estimation and log-rank tests to compare mortality and ESRD incidence as well as a composite of both endpoints in patient subsets stratified by NGAL quartile or creatinine quartile and by RIFLE stage visually and statistically.</s><s>Cox regression analysis was used to identify predictors of adverse outcomes including the following covariates: demographic variables (age, gender), comorbidites (CKD, hypertension, diabetes), RIFLE and AKIN classes of AKI, creatinine at the time of AKI, and uNGAL at the time of AKI.</s><s>Univariable Cox regression was used to identify individual significant predictors.</s><s>Significant predictors were then combined in a multivariable Cox regression analysis.</s><s>Backward elimination was used to construct a final Cox model.</s><s>P values for betweengroup comparisons were calculated using c 2 test, KruskalÀWallis test, or MannÀWhitney U test (as appropriate).</s><s>A P value &lt;0.05 was considered to be statistically significant.</s><s>To identify the prediction ability of uNGAL and serum creatinine regarding occurrence of the composite outcome (ESRD and death) within 6 months, we performed receiver operating characteristic (ROC) analyses.</s><s>Statistical analyses were performed using SPSS 22 and R 3.1.1</s><s>software.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>We studied 145 patients with hospital-acquired AKI according to RIFLE criteria at the time of AKI diagnosis.</s><s>The association of uNGAL in these patients with a diagnosis of intrinsic AKI and with short-term inhospital outcomes has been previously reported. <ref type="bibr" target="#b45">46</ref></s><s>We now report the results of clinical long-term follow-up of these patients (median follow-up, 6 months; range, &lt;1 to 45 months).</s><s>During the follow-up period, 22 patients (15.2%) developed ESRD (defined as a sustained requirement of renal replacement therapy), and 61 patients (42.1%) died.</s><s>A total of 74 patients (51%) experienced the composite outcome of ESRD or death.</s></p><p><s>Patients were stratified according to NGAL quartiles at the time of AKI diagnosis.</s><s>Baseline characteristics by NGAL quartile are shown in Table <ref type="table" target="#tab_0">1</ref>.</s><s>Age, sex, and comorbidities were distributed similarly among NGAL quartiles.</s><s>Patients within the highest uNGAL quartile had higher serum creatinine levels on inclusion and higher frequencies of stage 3 AKI.</s><s>Based on diagnostic adjudications that we had reported earlier in this cohort and consistent with the observations reported therein, <ref type="bibr" target="#b45">46</ref> patients in the higher uNGAL quartiles were more likely to have a diagnosis of intrinsic AKI, whereas patients with low uNGAL values were more likely to have prerenal AKI.</s><s>We found a stepwise increase in the frequency of the composite outcome according to quartiles of uNGAL levels.</s><s>In all, 78% of patients with NGAL levels $362 mg/l (corresponding to the highest quartile) experienced the composite outcome of death or ESRD during long-term follow-up, compared to 54.1% in the third NGAL quartile (95-362 mg/l), 38.9% in the second NGAL quartile (38-94 mg/l), and 33.3% in the lowest NGAL quartile (&lt;37 mg/l).</s><s>This finding indicated that NGAL levels at the time of AKI were strongly associated with poor long-term outcomes.</s><s>These observations were in close agreement with cutoffs defined in our earlier studies. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b45">46</ref></s><s>e next compared patients who developed the composite outcome with all other patients.</s><s>The 2 groups had similar demographic features, comorbidities, and creatinine levels on AKI diagnosis and displayed similar distributions regarding AKI severity based on creatinine criteria, as shown in Table <ref type="table" target="#tab_1">2</ref>.</s><s>In contrast, NGAL levels at the time of AKI diagnosis were significantly higher in patients who later experienced the composite outcome (629.0 vs. 221.5 mg/l; P ¼ 0.005).</s><s>To assess the diagnostic accuracy of uNGAL in diagnosing occurrence of the composite outcome (ESRD or death) at 6 months, we performed ROC analyses.</s><s>The ROCÀarea under the curve (AUC) for uNGAL was 0.73 (95% confidence interval [CI] ¼ 0.65-0.82),</s><s>which was substantially higher than the ROC-AUC for serum creatinine (0.58; 95% CI ¼ 0.48-0.68).</s><s>At a cutoff of 362 mg/l (75th percentile), uNGAL showed a sensitivity of 44% and specificity of 87% in Next, we performed multivariable Cox regression and performed backward selection, as shown in Table <ref type="table" target="#tab_2">3</ref>. uNGAL &gt; 362 mg/l and pre-existing CKD were independent significant predictors of the composite outcome.</s><s>uNGAL &gt;362 mg/l was associated with an adjusted hazard ratio of 3.03 (95% CI ¼ 1.86-4.94).</s><s>KaplanÀMeier analyses showed that patients within the upper 2 uNGAL quartiles had significantly increased occurrences of adverse long-term outcomes compared to patients in the lower uNGAL quartiles (P &lt; 0.001), as shown in Figure <ref type="figure" target="#fig_0">1</ref>.</s><s>After 6 months, 67% of patients in the highest uNGAL quartile had either progressed to ESRD or died, compared to 43% of patients in the third uNGAL quartile, and only 21% of patients in the lower quartiles (P &lt; 0.001).</s><s>Cox regression analyses showed that the highest uNGAL quartile and the third uNGAL quartile were associated with hazard ratios of 3.7 (95% CI ¼ 2.1-6.5;</s><s>P &lt; 0.001) and 1.9 (95% CI ¼ 1.1-3.5;</s><s>P &lt; 0.05), respectively, compared with the lower uNGAL quartiles.</s><s>In contrast, strata of creatinine levels were not significantly associated with the combined endpoint (P ¼ 0.534).</s><s>Therefore, high NGAL at presentation with AKI is an independent predictor of long-term all-cause mortality and the development of ESRD.</s><s>Since part of the predictive ability of NGAL levels may be assigned to its powerful prediction of poor short-term outcomes, <ref type="bibr" target="#b45">46</ref> we conducted a subgroup analysis to remove the influence of short-term outcomes, including only patients who had survived the AKI episode and who were discharged without a requirement for renal replacement therapy (N ¼ 107).</s><s>Of these patients, 5 developed ESRD and 32 died during long-term follow up.</s><s>Cox regression showed that NGAL at the time of AKI diagnosis remained an independent predictor of the combined endpoint in these patients and that creatinine had no association with long-term outcomes in these patients, as shown in Table <ref type="table" target="#tab_3">4</ref>. KaplanÀMeier analyses for this subgroup  showed that the third-and fourth-quartile uNGAL results were associated with significantly greater hazards of experiencing the composite outcome (P ¼ 0.002), as shown in Figure <ref type="figure" target="#fig_1">2</ref>. In contrast, increasing creatinine quartiles were not significantly associated with outcomes in this subgroup.</s><s>These data indicate that NGAL-positive AKI predicts poor long-term outcomes even in patients who initially recover from their AKI episode.</s></p><p><s>The predictive ability of uNGAL regarding long-term outcomes may be driven by the ability of uNGAL to distinguish prerenal and intrinsic AKI.</s><s>As reported in our previous investigation, <ref type="bibr" target="#b45">46</ref> 32 patients within our cohort had prerenal AKI and 75 patients had intrinsic AKI at the time of enrollment in the study (the remaining 38 patients could not be classified based on the available clinical data).</s><s>We used KaplanÀMeier analyses to compare long-term outcomes in patients with prerenal AKI and in those with intrinsic AKI.</s><s>As shown in Figure <ref type="figure" target="#fig_2">3</ref>, patients with intrinsic AKI progressed to ESRD or death more frequently than patients with prerenal AKI (Figure <ref type="figure" target="#fig_2">3</ref>, P ¼ 0.003 by log-rank test).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>This study is the first to demonstrate that uNGAL levels measured at the time of AKI diagnosis in the hospital are predictive of death or the development of ESRD in the long term.</s><s>Although the fact that AKI has an important impact on patients' long-term outcomes is well known, <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b47">48</ref> our study shows that uNGAL is superior to creatinine levels or AKI stage in assessing the long-term prognosis. In </s><s>ddition, our study is the first to assess the relative predictive value of uNGAL when compared to other predictors in the setting of AKI.</s><s>The difference in long-term outcomes may be driven by the distinct pathophysiology of prerenal and intrinsic AKI that is reflected by uNGAL levels.</s><s><ref type="bibr" target="#b45">46</ref> Previous studies have linked high NGAL levels with adverse long-term outcomes in other clinical settings.</s><s>For instance, Ralib et al. showed an association of uNGAL at the time of intensive care unit admission and Only patients who had survived the AKI episode and who were discharged without a requirement for renal replacement therapy were included (N ¼ 107).</s><s>The upper quartiles of NGAL, but not creatinine, remain associated with an increasing incidence of the composite outcome.</s></p><p><s>1-year mortality, but did not consider the presence or absence of an AKI diagnosis. <ref type="bibr" target="#b48">49</ref></s><s>Similarly, a recent longterm follow-up analysis of the Translational Research Investigating Biomarker Endpoints in AKI study in patients undergoing cardiac surgery found an association of perioperative peak uNGAL concentrations with long-term mortality rates.</s><s>Indeed, these authors observed a stepwise increase in mortality rates by tertile of uNGAL, irrespective of the presence or absence of postoperative AKI. <ref type="bibr" target="#b49">50</ref></s><s>Srisawat et al. <ref type="bibr" target="#b50">51</ref> showed in their study that elevated plasma NGAL levels in patients with AKI due to pneumonia were associated with short-term renal nonrecovery.</s><s>However, mortality as an outcome was not investigated, and uNGAL was not measured.</s><s>Another study in critically ill patients with AKI requiring RRT <ref type="bibr" target="#b51">52</ref> showed that relative changes in urinary NGAL values during the first 2 weeks after AKI predicted recovery of the kidney function with a ROC-AUC of 0.7.</s><s>This moderate performance may be explained by the relative short follow-up of 60 days and by the fact that mortality was not an aspect of the study endpoint.</s><s>Plasma NGAL predicted all-cause mortality in patients with hepatorenal syndrome. <ref type="bibr" target="#b52">53</ref></s><s>In patients after hepatobiliary surgery, uNGAL predicted worsening of the kidney function but not mortality during 6 months of follow-up. <ref type="bibr" target="#b53">54</ref></s><s>In a community-based study, uNGAL had a strong association with ESRD and all cause mortality in diabetic individuals at the 14-year follow-up. <ref type="bibr" target="#b54">55</ref></s><s>urthermore, several studies provide evidence that NGAL may be helpful in assessment of long-term (from 6 months up to 3 years) mortality in patients with chronic heart failure, <ref type="bibr" target="#b55">56,</ref><ref type="bibr" target="#b56">57</ref> acute heart failure, <ref type="bibr" target="#b57">58,</ref><ref type="bibr" target="#b58">59</ref> ST-elevation myocardial infarction, <ref type="bibr" target="#b59">60</ref> and elective percutaneous intervention due to stable angina pectoris. <ref type="bibr" target="#b60">61</ref></s><s>Together, these studies support a role for uNGAL measurements in assessing long-term prognosis and lend further plausibility to the findings reported herein.</s></p><p><s>In our study, neither RIFLE nor AKIN stage currently used to risk stratify patients with acute kidney injury contributed to the prediction of longterm mortality or ESRD.</s><s>This may be due to the fact that our study population included only patients with established AKI and hence lacked an internal comparator population without AKI.</s><s>In addition, the relatively small sample size of our study makes it difficult to find significant differences in long-term outcomes between different AKI stages.</s></p><p><s>In addition, serum creatinine at AKI diagnosis displayed weak associations with long-term outcomes when compared to uNGAL.</s><s>Although there was a slight increase in serum creatinine in patients groups in increasing uNGAL quartiles (from a median of 189.5 mmol/L in the lowest quartile to a median of 216.5 mmol/L in the highest quartile; P ¼ 0.061), there was still a large overlap of serum creatinine values between groups in different uNGAL quartiles (see the interquartile ranges of serum creatinine values in Table <ref type="table" target="#tab_0">1</ref>).</s><s>In fact, the correlation of uNGAL and serum creatinine was weak (correlation coefficient ¼ 0.272), as was the correlation between uNGAL quartile and serum creatinine quartile (correlation coefficient ¼ 0.189).</s><s>This explains why uNGAL quartiles and creatinine quartiles showed a markedly different association with longterm outcomes.</s></p><p><s>Other studies have clearly defined the impact of AKI on long-term outcomes, including death and ESRD.</s><s>For instance, in adult cardiac surgery patients, the presence of AKI according to RIFLE criteria predicted 90-day mortality with an ROC-AUC of 0.82. <ref type="bibr" target="#b61">62</ref></s><s>There was a stepwise increased mortality with advancing stages of AKI.</s><s>Children undergoing cardiac surgery had a higher 4-year mortality with AKI RIFLE F than without AKI (odds ratio ¼ 3.82, CI 1.89-7.75). <ref type="bibr" target="#b62">63</ref></s><s>A prospective study on adult cardiac surgery patients demonstrated that modified RIFLE I and F stages were independent predictors of long-term mortality (hazard ratio ¼ 2.35 and 3.09, respectively) compared to patients without AKI. <ref type="bibr" target="#b63">64</ref></s><s>n patients with acute myocardial infarction, AKI severity by RIFLE classification during the first week after hospitalization was an independent predictor of</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CLINICAL RESEARCH</head><p><s>2-year mortality (hazard ratio ¼ 8.1 and 19.3 for RIFLE I and F respectively). <ref type="bibr" target="#b64">65</ref> However, these results were not replicated in all studies.</s><s>In a population-based study, RIFLE predicted recovery of renal function, renal replacement therapy requirement, hospital length of stay, and in-hospital mortality, but not mortality at 90 days or 6 months. <ref type="bibr" target="#b65">66</ref></s><s>Also, 2-year mortality of neonates undergoing cardiac surgery was not different whether or not they developed AKI, regardless of AKIN stage. <ref type="bibr" target="#b66">67</ref></s><s>ur observations also underline the importance of distinguishing the pathophysiology of AKI to differentiate intrinsic from prerenal AKI, potentially aided by biomarkers such as uNGAL.</s><s>We found that patients with an adjudicated diagnosis of intrinsic AKI displayed significantly more adverse long-term outcomes with a cumulative incidence of &gt; 60% during a 2-year follow-up.</s><s>This incidence was significantly higher than that in patients with prerenal AKI, stressing the importance of distinguishing between different entities of AKI, not only for clinical management but also for prognostic assessment.</s><s>Surprisingly, however, long-term outcomes were also remarkably frequent in patients who were assigned a diagnosis of prerenal AKI, with 2-year mortality approaching 40%.</s><s>Although this may reflect adverse effects of prerenal azotemia, a more likely explanation lies in the fact that patients with prerenal AKI have severe comorbidities that predispose them to adverse long-term outcomes.</s><s>These observations are consistent with previous analyses showing not only that the duration of AKI has a positive association with mortality but that even transient AKI is associated with an elevated risk of death. <ref type="bibr" target="#b67">68</ref></s><s>n addition, we observed that pre-existing CKD was a significant predictor of long-term outcomes in our cohort.</s><s>We anticipated a role for pre-existing CKD as a predictor of long-term outcomes.</s><s>Notably, a large multicenter study <ref type="bibr" target="#b68">69</ref> demonstrated that patients with AKI on CKD during hospitalization had significantly worse long-term survival over a median follow-up of 4.8 years than patients with AKI but without CKD.</s></p><p><s>Our study has limitations.</s><s>We conducted our analysis in a relatively small cohort at a single center.</s><s>The definition of AKI in our study relied solely on creatinine dynamics.</s><s>Urinary output was not assessed in our study, as most of our patients had AKI outside the intensive care unit setting.</s><s>In addition, our study was not sufficiently powered to assess the individual components of the composite endpoint (mortality and ESRD) separately.</s><s>This issue will need to be addressed in larger future cohorts.</s><s>In addition, we do not have detailed information regarding the cause of death for most patients.</s><s>However, our analysis including only patients who were alive and dialysis free on hospital discharge indicates that even when the initial episode of critical illness is survived, patients with NGAL-positive AKI remain at an increased risk for death or ESRD.</s><s>Hence, further studies are needed to assess the longterm prognostic impact of uNGAL in patients with established AKI.</s></p><p><s>Long-term management of patients with AKI is currently suboptimal. <ref type="bibr" target="#b69">70,</ref><ref type="bibr" target="#b70">71</ref></s><s>Evidence exists that patients who experience AKI episodes are not followed up systematically in the health care system.</s><s>This state of affairs is concerning, especially given that multiple potential medical interventions exist.</s><s>]<ref type="bibr" target="#b76">[77]</ref><ref type="bibr" target="#b77">[78]</ref><ref type="bibr" target="#b78">[79]</ref> The current uncertainty regarding post-AKI management may be due in part to the wide range of outcomes in post-AKI patients, ranging from complete restitution of kidney function to quick progression to CKD.</s><s>A parameter that predicts adverse clinical courses in the setting of AKI would help to prioritize patients' followup, for example by nephrologists, during patients' hospital stay.</s><s>Hence, determining uNGAL levels at the time of AKI diagnosis, in addition to improving diagnostic assessment, <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b45">46</ref> may help in the selection of patients who require close medical attention after their hospital stay.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCLOSURE</head><p><s>KMSO has received license revenue related to the use of the NGAL assay.</s><s>All the other authors declared no competing interests.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Cumulative incidence of the composite outcome of death or end-stage renal disease in acute kidney injury patients stratified by neutrophil gelatinaseÀassociated lipocalin (NGAL) (a) and creatinine (b).</s><s>The upper quartiles of NGAL, but not creatinine, are associated with an increasing incidence of the composite outcome.</s></p></div></figDesc><graphic coords="5,51.82,48.64,508.07,348.61" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Subgroup analysis of cumulative incidence of the composite outcome of death or end-stage renal disease in acute kidney injury (AKI) patients stratified by neutrophil gelatinaseÀassociated lipocalin (NGAL) (a) and creatinine (b).Only patients who had survived the AKI episode and who were discharged without a requirement for renal replacement therapy were included (N ¼ 107).</s><s>The upper quartiles of NGAL, but not creatinine, remain associated with an increasing incidence of the composite outcome.</s></p></div></figDesc><graphic coords="6,51.82,347.81,508.07,347.02" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Cumulative incidence of the composite outcome of death or end-stage renal disease in patients with intrinsic and prerenal acute kidney injury (AKI; P ¼ 0.003 by log-rank test).</s></p></div></figDesc><graphic coords="7,52.10,48.64,239.02,283.24" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Patient characteristics according to NGAL quartile at the time of AKI</s></p></div></figDesc><table><row><cell></cell><cell>NGAL</cell><cell>NGAL</cell><cell>NGAL</cell><cell>NGAL</cell><cell></cell></row><row><cell></cell><cell>quartile 1</cell><cell>quartile 2</cell><cell>quartile 3</cell><cell>quartile 4</cell><cell></cell></row><row><cell>Patient characteristics by NGAL quartile</cell><cell>(&lt;38 mg/l)</cell><cell>(38--95 mg/l)</cell><cell>(95--362 mg/l)</cell><cell>(&gt;362 mg/l)</cell><cell>P value</cell></row><row><cell>Mean age, yr (SD)</cell><cell>65.8 (13.3)</cell><cell>70.8 (9.9)</cell><cell>67.3 (17.4)</cell><cell>66.9 (15.9)</cell><cell>0.664 a</cell></row><row><cell>Female sex, n (%)</cell><cell>13 (36.1%)</cell><cell>17 (47.2%)</cell><cell>17 (45.9%)</cell><cell>12 (33.3%)</cell><cell>0.536 b</cell></row><row><cell>History of chronic kidney disease, n (%)</cell><cell>8 (22.2%)</cell><cell>9 (25.0%)</cell><cell>12 (32.4%)</cell><cell>9 (25.0%)</cell><cell>0.779 b</cell></row><row><cell>Hypertension, n (%)</cell><cell>30 (83.3%)</cell><cell>30 (83.3%)</cell><cell>33 (89.2%)</cell><cell>25 (69.4%)</cell><cell>0.168 b</cell></row><row><cell>Diabetes, n (%)</cell><cell>12 (33.3%)</cell><cell>10 (27.8%)</cell><cell>13 (35.1%)</cell><cell>7 (19.4%)</cell><cell>0.452 b</cell></row><row><cell>Median baseline creatinine (95% CI)</cell><cell>83.5 (71.1-95.0)</cell><cell>89.5 (74.0-96.0)</cell><cell>88.0 (80.0-100.0)</cell><cell>83.0 (72.0-100.0)</cell><cell>0.870 a</cell></row><row><cell>Median serum creatinine (95% CI)</cell><cell>189.5 (155.0-224.0)</cell><cell>176.0 (164.6-229.5)</cell><cell>207.0 (188.5-238.0)</cell><cell>216.5 (192.0-315.0)</cell><cell>0.061 a</cell></row><row><cell>RIFLE-F, n (%)</cell><cell>9 (25%)</cell><cell>11 (30.6%)</cell><cell>10 (27.0%)</cell><cell>13 (36.1%)</cell><cell>0.361 b</cell></row><row><cell>AKIN-3, n (%)</cell><cell>9 (25%)</cell><cell>11 (30.6%)</cell><cell>10 (27.0%)</cell><cell>14 (38.9%)</cell><cell>0.272 b</cell></row><row><cell>Prerenal AKI, n (%)</cell><cell>16 (44.4%)</cell><cell>10 (27.8%)</cell><cell>5 (13.5%)</cell><cell>1 (2.8%)</cell><cell>&lt;0.001 b</cell></row><row><cell>Intrinsic AKI, n (%)</cell><cell>7 (19.4%)</cell><cell>12 (33.3%)</cell><cell>25 (67.6%)</cell><cell>31 (86.1%)</cell><cell>&lt;0.001 b</cell></row><row><cell>Development of ESRD during follow-up, n (%)</cell><cell>2 (5.6%)</cell><cell>4 (11.1%)</cell><cell>5 (13.5%)</cell><cell>11 (30.6%)</cell><cell>0.021 b</cell></row><row><cell>Death during follow-up, n (%)</cell><cell>11 (30.6%)</cell><cell>12 (33.3%)</cell><cell>17 (45.9%)</cell><cell>21 (58.3%)</cell><cell>0.065 b</cell></row><row><cell>Death or ESRD during follow-up, n (%)</cell><cell>12 (33.3%)</cell><cell>14 (38.9%)</cell><cell>20 (54.1%)</cell><cell>28 (77.8%)</cell><cell>0.001</cell></row></table><note><p><s>b AKI, acute kidney injury; AKIN, Acute Kidney Injury Network; CI, confidence interval; ESRD, end-stage renal disease; NGAL, neutrophil gelatinaseÀassociated lipocalin; RIFLE, Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease.</s><s>Median follow-up for outcomes: 6 months.</s><s>a KruskalÀWallis test.</s><s>b c 2 Test.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Patient characteristics according to outcome AKI, acute kidney injury; AKIN, Acute Kidney Injury Network; CI, confidence interval; ESRD, end-stage renal disease; NGAL, neutrophil gelatinaseÀassociated lipocalin; RIFLE, Risk, Injury, Failure, Loss of kidney function.</s><s>Median follow-up for outcomes: 6 months.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell>Outcome</cell><cell></cell></row><row><cell>Patient characteristics by outcome</cell><cell>Total cohort</cell><cell>Neither ESRD nor death</cell><cell>Composite (ESRD or death)</cell><cell>P value</cell></row><row><cell>Total number, n</cell><cell>145</cell><cell>71</cell><cell>74</cell><cell></cell></row><row><cell>Mean age, yr (SD)</cell><cell>67.7 (14.4)</cell><cell>66,9 (15.0)</cell><cell>68.5 (13.9)</cell><cell>0.585 a</cell></row><row><cell>Female sex, n (%)</cell><cell>59 (40.7%)</cell><cell>31 (43.7%)</cell><cell>28 (37.8%)</cell><cell>0.475 b</cell></row><row><cell>History of chronic kidney disease, n (%)</cell><cell>38 (26.2%)</cell><cell>16 (22.5%)</cell><cell>22 (29.7%)</cell><cell>0.325 b</cell></row><row><cell>Hypertension, n (%)</cell><cell>118 (81.4%)</cell><cell>58 (81.7%)</cell><cell>60 (81.1%)</cell><cell>0.925 b</cell></row><row><cell>Diabetes, n (%)</cell><cell>42 (29.0%)</cell><cell>21 (29.6%)</cell><cell>21 (28.4%)</cell><cell>0.874 b</cell></row><row><cell>Median baseline creatinine (mmol/l) (95% CI)</cell><cell>87 (79-91)</cell><cell>88 (78-95)</cell><cell>86.5 (77-99)</cell><cell>0.291 a</cell></row><row><cell>Median serum creatinine on inclusion (mmol/l) (95% CI)</cell><cell>202 (189-220)</cell><cell>188 (174-224)</cell><cell>205.5 (192-229)</cell><cell>0.284 a</cell></row><row><cell>RIFLE stage F, n (%)</cell><cell>43 (29.7%)</cell><cell>19 (26.8%)</cell><cell>24 (32.4%)</cell><cell>0.646 b</cell></row><row><cell>AKIN stage 3, n (%)</cell><cell>44 (30.3%)</cell><cell>19 (26.8%)</cell><cell>25 (33.8%)</cell><cell>0.506 b</cell></row><row><cell>Median NGAL (mg/l) (95% CI)</cell><cell>95.4 (71.0 À120,5)</cell><cell>56.0 (46.6-78.4)</cell><cell>208.1 (114.9-329.9)</cell><cell>&lt;0.001 a</cell></row><row><cell>Prerenal AKI, n (%)</cell><cell>32 (22.1%)</cell><cell>21 (29.6%)</cell><cell>11 (14.9%)</cell><cell>0.033 b</cell></row><row><cell>Intrinsic AKI, n (%)</cell><cell>75 (51.7%)</cell><cell>27 (38.0%)</cell><cell>48 (64.9%)</cell><cell>0.001 b</cell></row></table><note><p><s>a MannÀWhitney U test.</s><s>b c 2 Test.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Univariable and multivariable Cox regression analysis on the entire cohort of AKI patients (N ¼ 145)</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Univariable Cox regression</cell><cell></cell><cell cols="3">Multivariable model using significant covariates</cell></row><row><cell>Prediction of composite outcome (death or ESRD)</cell><cell>Hazard ratio</cell><cell>95% CI</cell><cell>P value</cell><cell>Hazard ratio</cell><cell>95% CI</cell><cell>P value</cell></row><row><cell>Age (per 10 yr)</cell><cell>1.06</cell><cell>0.9-1.25</cell><cell>0.493</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Female sex</cell><cell>0.96</cell><cell>0.6-1.53</cell><cell>0.850</cell><cell></cell><cell></cell><cell></cell></row><row><cell>History of chronic kidney disease</cell><cell>1.61</cell><cell>0.97-2.67</cell><cell>0.065</cell><cell>1.77</cell><cell>1.06-2.96</cell><cell>0.028</cell></row><row><cell>Hypertension</cell><cell>1</cell><cell>0.56-1.8</cell><cell>0.993</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Diabetes mellitus</cell><cell>0.94</cell><cell>0.57-1.56</cell><cell>0.806</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Serum creatinine on inclusion &gt;264 mmol/l</cell><cell>1.15</cell><cell>0.67-1.95</cell><cell>0.614</cell><cell></cell><cell></cell><cell></cell></row><row><cell>RIFLE class (1-3) on inclusion</cell><cell>1.13</cell><cell>0.82-1.55</cell><cell>0.448</cell><cell></cell><cell></cell><cell></cell></row><row><cell>AKIN class (1-3) on inclusion</cell><cell>1.15</cell><cell>0.87-1.51</cell><cell>0.335</cell><cell></cell><cell></cell><cell></cell></row><row><cell>uNGAL on inclusion &gt; 362 mg/l</cell><cell>2.87</cell><cell>1.77-4.66</cell><cell>&lt;0.001</cell><cell>3.03</cell><cell>1.86-4.94</cell><cell>&lt;0.001</cell></row></table><note><p><s>AKI, acute kidney injury; AKIN, Acute Kidney Injury Network; CI ¼ confidence interval; ESRD, end-stage renal disease; RIFLE, Risk, Injury, Failure, Loss of kidney function; uNGAL, urinary neutrophil gelatinaseÀassociated lipocalin.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 .</head><label>4</label><figDesc><div><p><s>Univariable and multivariable Cox regression analysis on the subpopulation of patients who had survived the AKI episode and who were discharged without a requirement for renal replacement therapy</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Univariate Cox regression</cell><cell></cell><cell cols="3">Multivariable model using significant covariates</cell></row><row><cell>Prediction of composite outcome (death or ESRD)</cell><cell>Hazard ratio</cell><cell>95% CI</cell><cell>P value</cell><cell>Hazard ratio</cell><cell>95% CI</cell><cell>P value</cell></row><row><cell>Age (per 10 yr)</cell><cell>1.39</cell><cell>1.06-1.83</cell><cell>0.019</cell><cell>1.42</cell><cell>1.09-1.85</cell><cell>0.010</cell></row><row><cell>Female sex</cell><cell>0.84</cell><cell>0.42-1.69</cell><cell>0.628</cell><cell></cell><cell></cell><cell></cell></row><row><cell>History of chronic kidney disease</cell><cell>1.3</cell><cell>0.57-2.98</cell><cell>0.534</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Hypertension</cell><cell>1.49</cell><cell>0.58-3.85</cell><cell>0.406</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Diabetes mellitus</cell><cell>0.88</cell><cell>0.42-1.82</cell><cell>0.728</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Serum creatinine on inclusion &gt;264 mmol/l</cell><cell>0.66</cell><cell>0.26-1.70</cell><cell>0.392</cell><cell></cell><cell></cell><cell></cell></row><row><cell>RIFLE class (1-3) on inclusion</cell><cell>0.77</cell><cell>0.49-1.22</cell><cell>0.259</cell><cell></cell><cell></cell><cell></cell></row><row><cell>AKIN class (1-3) on inclusion</cell><cell>0.8</cell><cell>0.53-1.23</cell><cell>0.308</cell><cell></cell><cell></cell><cell></cell></row><row><cell>uNGAL on inclusion &gt;362 mg/l</cell><cell>3.48</cell><cell>1.70-7.12</cell><cell>0.001</cell><cell>3.93</cell><cell>1.90-8.13</cell><cell>&lt;0.001</cell></row></table><note><p><s>AKI, acute kidney injury; AKIN, Acute Kidney Injury Network; CI, confidence interval; ESRD, end-stage renal disease; RIFLE, Risk, Injury, Failure, Loss of kidney function; uNGAL, urinary neutrophil gelatinaseÀassociated lipocalin.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Kidney International Reports (2016) 1, 114-124</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">E Singer et al.: NGAL, AKI, and Long-term Outcomes</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>The Deutsche Forschungsgemeinschaft (Schm 1730/2-1, Schm 1730/3-1, Schm 1730/5-2, Schm 1730/6-2) and the Urological Research Foundation, Berlin, Germany, supported the study.</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Hospital-acquired renal insufficiency</title>
		<author>
			<persName><forename type="first">K</forename><surname>Nash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hafeez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="930" to="936" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Acute kidney injury is associated with higher morbidity and resource utilization in pediatric patients undergoing heart surgery</title>
		<author>
			<persName><forename type="first">R</forename><surname>Tóth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Breuer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Cserép</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1984" to="1990" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Independent association between acute renal failure and mortality following cardiac surgery</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Chertow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Hammermeister</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="343" to="348" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Acute kidney injury increases risk of ESRD among elderly</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ishani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Himmelfarb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="223" to="228" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Risk of chronic dialysis and death following acute kidney injury</title>
		<author>
			<persName><forename type="first">R</forename><surname>Wald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Adhikari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="585" to="593" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Chronic dialysis and death among survivors of acute kidney injury requiring dialysis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Wald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Luo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="page" from="1179" to="1185" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Acute renal failureedefinition, outcome measures, animal models, fluid therapy and information technology needs: the</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ronco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group</title>
				<imprint>
			<date type="published" when="2004">2004</date>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="R204" to="R212" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Acute kidney injury, mortality, length of stay, and costs in hospitalized patients</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Chertow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Burdick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Honour</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="3365" to="3370" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with preexistent chronic renal insufficiency</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gruberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Mintz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mehran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1542" to="1548" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Early changes in organ function predict eventual survival in severe sepsis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Macias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-L</forename><surname>Vincent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="2194" to="2201" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Contrast-induced nephropathy</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Mccullough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Soman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Clin</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="261" to="280" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Are small changes in serum creatinine an important risk factor?</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Praught</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Shlipak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Nephrol Hypertens</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="265" to="270" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Shah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">R31</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury</title>
	</analytic>
	<monogr>
		<title level="j">Kidney Int Suppl</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1" to="138" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE criteria</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Bolgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Perazella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="418" to="425" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">An assessment of the RIFLE criteria for acute renal failure in hospitalized patients</title>
		<author>
			<persName><forename type="first">S</forename><surname>Uchino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldsmith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1913" to="1917" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Siew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Ware</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gebretsadik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1823" to="1832" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Acute kidney injury (AKI) biomarker</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Adiyanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Loho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Med Indones</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="246" to="255" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Biomarkers of acute kidney injury</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Edelstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Chron Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="222" to="234" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Performance of urinary NGAL and L-FABP in predicting acute kidney injury and subsequent renal recovery: a cohort study based on major surgeries</title>
		<author>
			<persName><forename type="first">X-F</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem Lab Med</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="671" to="678" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Nickolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Schmidt-Ott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Canetta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="246" to="255" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Additive value of blood neutrophil gelatinase-associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department</title>
		<author>
			<persName><forename type="first">Di</forename><surname>Somma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Magrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Berardinis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">R29</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective</title>
		<author>
			<persName><forename type="first">C</forename><surname>Ronco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Legrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Goldstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Purif</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="271" to="285" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative consensus conference</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Mccullough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haase</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Contrib Nephrol</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="page" from="13" to="29" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shaw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="513" to="521" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zappitelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Washburn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Arikan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">R84</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Wheeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Devarajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Ma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1297" to="1303" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Cal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Garzotto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="444" to="451" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients</title>
		<author>
			<persName><forename type="first">Hrh</forename><surname>De Geus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bakker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Emeh</forename><surname>Lesaffre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="907" to="914" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">The clinical utility of plasma neutrophil gelatinase-associated lipocalin in acute kidney injury</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Pickering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">H</forename><surname>Endre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Purif</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="295" to="302" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Bagshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haase</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="452" to="461" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Plasma neutrophil gelatinaseassociated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Cruz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Biochem</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1414" to="1418" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bachorzewska-Gajewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Malyszko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sitniewska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Nephrol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="287" to="292" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">NGAL is an early predictive biomarker of contrast-induced nephropathy in children</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pfriem</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Nephrol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="2089" to="2095" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Neutrophil gelatinaseassociated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mishra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tarabishi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">365</biblScope>
			<biblScope unit="page" from="1231" to="1238" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Plasma neutrophil gelatinaseassociated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Dent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dastrala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">R127</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Dent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Ma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="665" to="673" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Muehlschlegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K-Y</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anesth Analg</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="1541" to="1547" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Coca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thiessen-Philbrook</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1748" to="1757" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgeryea prospective cohort study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Haase-Fielitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Devarajan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="553" to="560" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Koyner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Vaidya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Bennett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="2154" to="2165" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Nickolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>O'rourke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="810" to="819" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kümpers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hafer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lukasz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">R9</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in acute kidney injury</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Boo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M-G</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Nephrol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="501" to="509" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit</title>
		<author>
			<persName><forename type="first">K</forename><surname>Doi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Negishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ishizu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="2464" to="2469" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes</title>
		<author>
			<persName><forename type="first">E</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Elger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Elitok</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="405" to="414" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Grenier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Syed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Biochem</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="615" to="620" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Impact of contrastinduced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yasuoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Adachi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Revasc Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="253" to="257" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Ralib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Pickering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Shaw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="322" to="333" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Urinary biomarkers of AKI and mortality 3 years after cardiac surgery</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Coca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">X</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thiessen-Philbrook</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1063" to="1071" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia</title>
		<author>
			<persName><forename type="first">N</forename><surname>Srisawat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Murugan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="545" to="552" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Urinary biomarkers and renal recovery in critically ill patients with renal support</title>
		<author>
			<persName><forename type="first">N</forename><surname>Srisawat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1815" to="1823" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Neutrophil gelatinaseassociated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Gungor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ataseven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Demir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Liver Int</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="49" to="57" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">The incidence and risk factors of acute kidney injury after hepatobiliary surgery: a prospective observational study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S-C</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M-G</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Nephrol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">169</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Fufaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Weil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Nelson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Clinical outcome of renal tubular damage in chronic heart failure</title>
		<author>
			<persName><forename type="first">K</forename><surname>Damman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Masson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Hillege</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="2705" to="2712" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bolignano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Basile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Parisi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rejuvenat Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="7" to="14" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure</title>
		<author>
			<persName><forename type="first">A</forename><surname>Palazzuoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ruocco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beltrami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acute Card Care</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="93" to="101" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Van Deursen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Damman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Voors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Heart Fail</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="35" to="42" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Pedersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mogelvang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="339" to="345" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Does neutrophil gelatinase-asociated lipocalin have prognostic value in patients with stable angina undergoing elective PCI? A 3-year follow-up study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bachorzewska-Gajewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tomaszuk-Kazberuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Jarocka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Blood Press Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="280" to="285" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Acute renal failure after cardiac surgery: evaluation of the RIFLE classification</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kuitunen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vento</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Suojaranta-Ylinen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="542" to="546" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Long-term mortality associated with acute kidney injury in children following congenital cardiac surgery</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Watkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Williamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Davidson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Paediatr Anaesth</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="919" to="926" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Influence of acute kidney injury on short-and long-term outcomes in patients undergoing cardiac surgery: risk factors and prognostic value of a modified RIFLE classification</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Lopez-Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Esteve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Torrado</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">R293</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Renal dysfunction on admission, worsening renal function, and severity of acute kidney injury predict 2-year mortality in patients with acute myocardial infarction</title>
		<author>
			<persName><forename type="first">M-J</forename><surname>Hsieh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y-C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-C</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ J</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="217" to="223" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Incidence and outcomes in acute kidney injury: a comprehensive population-based study</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Simpson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1292" to="1298" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Risk factors for and outcomes of acute kidney injury in neonates undergoing complex cardiac surgery</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zappitelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cmt</forename><surname>Robertson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="120" to="127" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Transient azotaemia is associated with a high risk of death in hospitalized patients</title>
		<author>
			<persName><forename type="first">S</forename><surname>Uchino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Bagshaw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1833" to="1839" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality</title>
		<author>
			<persName><forename type="first">V-C</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T-M</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-F</forename><surname>Lai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="1222" to="1230" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Acute kidney injury leading to chronic kidney disease and long-term outcomes of acute kidney injury: the best opportunity to mitigate acute kidney injury?</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Chawla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Contrib Nephrol</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="page" from="182" to="190" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Long-term follow-up of patients after acute kidney injury: patterns of renal functional recovery</title>
		<author>
			<persName><forename type="first">E</forename><surname>Macedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dmt</forename><surname>Zanetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rcrm</forename><surname>Abdulkader</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e36388</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lewington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Qizilbash</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="page" from="1903" to="1913" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Adler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Stratton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Neil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">321</biblScope>
			<biblScope unit="page" from="412" to="419" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes</title>
		<author>
			<persName><forename type="first">V</forename><surname>Papademetriou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lovato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Doumas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Koren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="741" to="750" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS)</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Colhoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Betteridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Durrington</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="810" to="819" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Shepherd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jjp</forename><surname>Kastelein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bittner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1131" to="1139" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tonelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Moyé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Sacks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="98" to="104" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Shepherd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jjp</forename><surname>Kastelein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bittner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1448" to="1454" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
